Key points are not available for this paper at this time.
OBJECTIVE: To estimate the direct medical and indirect (absenteeism and short-term disability) cost burden of Crohn's Disease (CD) and Ulcerative Colitis (UC). METHODS: Data were obtained from 1999 to 2005 MarketScan databases. Twelve-month expenditures for patients with CD and UC were compared to expenditures among an equal number of propensity score matched comparison group patients. Regression analysis controlled for demographics and case-mix. RESULTS: Annual medical expenditures were significantly higher for commercially insured CD and UC patients compared to matched comparison group patients (18, 963 vs 5300 for CD patients, 15, 020 vs 4982 for UC patients, respectively, all P < 0. 001). Indirect costs were also high for employed patients with these conditions. CONCLUSIONS: CD and UC are costly diseases with a significant cost burden related to health care utilization and productivity loss.
Gibson et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: